About Terminal nucleotidyltransferase 5C
Terminal nucleotidyltransferase 5C (TENT5C) is a protein
from Homo sapiens identified by UniProt accession
Q5VWP2, 391 residues long.
MolForge cross-references it against 0 known binders and
349 disease associations.
Target properties
| Protein name | Terminal nucleotidyltransferase 5C |
| UniProt accession | Q5VWP2 |
| Gene | TENT5C |
| Organism | Homo sapiens |
| Length | 391 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (349)
Diseases linked to this target (Open Targets).
- reticulocyte count · score 0.65
- reticulocyte measurement · score 0.63
- mean corpuscular volume · score 0.59
- mean corpuscular hemoglobin · score 0.59
- multiple myeloma · score 0.57
- mean corpuscular hemoglobin concentration · score 0.54
- Red cell distribution width · score 0.48
- platelet count · score 0.47
- mean platelet volume · score 0.47
- erythrocyte count · score 0.47
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5VWP2-F1 | alphafold | PREDICTED | 87.24 | — |
Amino-acid sequence (391 residues)
MAEESSCTRD CMSFSVLNWD QVSRLHEVLT EVVPIHGRGN FPTLEITLKD IVQTVRSRLE EAGIKVHDVR LNGSAAGHVL VKDNGLGCKD LDLIFHVALP TEAEFQLVRD VVLCSLLNFL PEGVNKLKIS PVTLKEAYVQ KLVKVCTDTD RWSLISLSNK NGKNVELKFV DSIRRQFEFS VDSFQIILDS LLFFYDCSNN PISEHFHPTV IGESMYGDFE EAFDHLQNRL IATKNPEEIR GGGLLKYSNL LVRDFRPTDQ EEIKTLERYM CSRFFIDFPD ILEQQRKLET YLQNHFAEEE RSKYDYLMIL RRVVNESTVC LMGHERRQTL NLISLLALRV LAEQNIIPSA TNVTCYYQPA PYVSDGNFSN YYVAHPPVTY SQPYPTWLPC N
Explore Terminal nucleotidyltransferase 5C with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets